Mode of delivery: 

Course duration: 2 days

Course dates: For available course dates, scroll to the bottom of this catalogue entry. Note: spaces may be reserved for Peter Mac staff or open for sign-ups from the general public. Ensure a relevant space is available by checking the listings below before purchasing this course. 

Pre-requisites: 

Whilst completion of Haematology Module 1 is not a pre-requisite, knowledge of haematological malignancies and/or clinical experience managing patients with haematological malignancies will be beneficial in understanding content.

Peter Mac staff members require manager approval to attend this course. No prerequisites exist for external participants. 

Audience: This course is open to nurses and allied health staff. 

About this learning program:

This is a two day intermediate program aimed at nurses and allied health clinicians engaged in the care of patients with haematological malignancies, requiring complex care.

Learning Objectives & Learning Outcomes:

Upon completion of the course you should be able to:

• Identify advances in the laboratory in the management of and implications for practice
• Identify infection issues in the immunocompromised patient
• Recognise the impact and benefits of research in quality patient care
• Discuss treatment toxicities that impact survivorship
• Identify acute toxicities (e.g. Cytokine Release Syndrome/Venous thrombotic events) in patient with a haematological malignancy
• Recognise innovative treatments for lymphoma and myeloma
• Discuss Car T-cell Therapy, the product and it’s application to clinical practice
• Identify recent updates for specific tumour streams, including patient education and support in myeloma, the role of allografting in cutaneous lymphoma and Outpatient treatment in acute leukaemia
• State the implications for prehabilitation and effective palliative care on nursing care and the patient journey
• Discuss key issues impacting the Adolescent & Young Adult (AYA) with a haematological malignancy

On completion of the program, participants will be able to identify a number of current and emerging treatment and disease based issues impacting the patient with a haematological malignancy and outline the implications for the clinical care of this patient cohort.

What will I get when I have completed this course? 
Upon attendance of the training session, learners will obtain a Certificate of Completion as proof of training.  

How to enrol: Click the "add to cart" checkbox on the course icon above to select this course.  Once you have added all required courses to your cart, scroll to the top of this catalogue page to view your cart and purchase or enrol in your course(s). After you have purchased your course, access the course page and sign up to your desired session time. 

Note: Available session times are listed below, Ensure a session time which suits you is available before purchasing this course. Spaces may be reserved for Peter Mac staff or open for sign-ups from the general public. 

Disclaimer - Peter Mac Staff: by enrolling in this course, you are confirming that:

1. You have approval from your line manager/delegate to enrol in this program and attend at your selected date/time. 
2. Your line manager/delegate has approved this program as relevant to your clinical practice and will support completion of relevant clinical competency assessments.